Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Preventive Healthcare Services01:30

Preventive Healthcare Services

2.3K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.2K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.2K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

879
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
879
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Long-term Depression01:03

Long-term Depression

3.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful use of carbamazepine in a patient with drug rash with eosinophilia and systemic symptoms.

The mental health clinician·2019
Same author

Diagnosis of Neurosyphilis in a Collaborative Care Setting.

The primary care companion for CNS disorders·2019
Same author

Implementing the Collaborative Care Model as Part of a Countywide Initiative.

Psychiatric services (Washington, D.C.)·2016
Same author

CPT changes and their effects on billing in an outpatient clinic.

Psychiatric services (Washington, D.C.)·2015
Same author

Screening for depression in the primary care population.

Primary care·2014
Same author

Opportunities and challenges: residents' perspectives on the next accreditation system in psychiatry.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014

Related Experiment Video

Updated: Apr 16, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.7K

Screening for depression in the primary care population.

D Edward Deneke1, Heather E Schultz2, Thomas E Fluent1

  • 1Department of Psychiatry, University of Michigan Health System, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI 48109-2700, USA.

The Psychiatric Clinics of North America
|March 2, 2015
PubMed
Summary

Diagnosing and treating depression in primary care faces hurdles. Effective depression screening requires robust care systems, but new models struggle with funding and clinical culture, despite the Affordable Care Act

Keywords:
DepressionPrimary careScreeningSuicide

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

30.0K

Related Experiment Videos

Last Updated: Apr 16, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.7K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

30.0K

Area of Science:

  • Primary Care Medicine
  • Mental Health Services Research

Background:

  • Depression diagnosis and treatment present significant challenges within primary care settings.
  • Effective depression screening necessitates integrated care systems for clinician treatment and patient adherence.
  • Existing evidence-based depression care models face slow adoption due to funding and cultural barriers.

Purpose of the Study:

  • To examine the challenges in primary care depression management.
  • To explore the impact of the Affordable Care Act on collaborative care models for depression.
  • To address the slow dissemination of evidence-based depression care.

Main Methods:

  • Review of current literature on depression care in primary care.
  • Analysis of existing evidence-based collaborative care models.
  • Assessment of potential impacts of healthcare policy changes on care delivery.

Main Results:

  • Screening effectiveness is contingent upon reliable systems for treatment and adherence.
  • Inadequate funding and clinical culture impede the spread of new depression care models.
  • The Affordable Care Act may offer opportunities to restructure funding for collaborative care.

Conclusions:

  • Improving depression care in primary care requires addressing systemic issues beyond screening.
  • Policy changes like the Affordable Care Act could facilitate the adoption of collaborative care.
  • Suicide screening in primary care remains a complex and debated issue.